alphaB-crystallin is a novel predictor of resistance to neoadjuvant chemotherapy in breast cancer.
Ivanov O, Chen F, Wiley EL, Keswani A, Diaz LK, Memmel HC, Rademaker A, Gradishar WJ, Morrow M, Khan SA, Cryns VL.
Ivanov O, et al. Among authors: diaz lk.
Breast Cancer Res Treat. 2008 Oct;111(3):411-7. doi: 10.1007/s10549-007-9796-0. Epub 2007 Oct 30.
Breast Cancer Res Treat. 2008.
PMID: 17968656